Drug class
Immunosuppressants - Antiproliferative Agents
Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism. Read more about Immunosuppressants - Antiproliferative Agents
71 drugs in this class 51 manufacturers
Drugs in Immunosuppressants - Antiproliferative Agents
AZATHIOPRINE
AZASAN (azathioprine)
MYFORTIC (mycophenolate sodium)
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism.
By arresting cell division, these agents selectively impair the rapid clonal expansion of activated T and B lymphocytes that lack alternative salvage pathways for nucleotide generation.
They serve as vital components of maintenance regimens to prevent allograft rejection in solid organ transplantation and are widely used to treat refractory autoimmune and inflammatory diseases, such as systemic lupus erythematosus, lupus nephritis, and rheumatoid arthritis.
-
nih.gov
Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism By arresting cell division, these agents selectively impair the rapid clonal expansion of activated T and B lymphocytes that lack alternative salvage pathways for nucleotide generation They serve as vital components of maintenance regimens to p...
-
nih.gov
Antiproliferative immunosuppressants are a therapeutic category of medications, most prominently represented by mycophenolate derivatives and azathioprine, that suppress immune activity by inhibiting purine synthesis and disrupting nucleic acid metabolism They serve as vital components of maintenance regimens to prevent allograft rejection in solid organ transplantation and are widely used to treat refractory autoimmune and inflammatory diseases, such as systemic lupus erythematosus, lupus nephr...
-
nih.gov
By arresting cell division, these agents selectively impair the rapid clonal expansion of activated T and B lymphocytes that lack alternative salvage pathways for nucleotide generation They serve as vital components of maintenance regimens to prevent allograft rejection in solid organ transplantation and are widely used to treat refractory autoimmune and inflammatory diseases, such as systemic lupus erythematosus, lupus nephritis, and rheumatoid arthritis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.